These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

725 related articles for article (PubMed ID: 26037892)

  • 21. High mucin-7 expression is an independent predictor of adverse clinical outcomes in patients with clear-cell renal cell carcinoma.
    NguyenHoang S; Liu Y; Xu L; Chang Y; Zhou L; Liu Z; Lin Z; Xu J
    Tumour Biol; 2016 Nov; 37(11):15193-15201. PubMed ID: 27683054
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Decreased expression of CTR2 predicts poor prognosis of patients with clear cell renal cell carcinoma.
    Xia Y; Liu L; Long Q; Bai Q; Wang J; Xu J; Guo J
    Urol Oncol; 2016 Jan; 34(1):5.e1-9. PubMed ID: 26411550
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fatty acid binding protein 7 may be a marker and therapeutic targets in clear cell renal cell carcinoma.
    Nagao K; Shinohara N; Smit F; de Weijert M; Jannink S; Owada Y; Mulders P; Oosterwijk E; Matsuyama H
    BMC Cancer; 2018 Nov; 18(1):1114. PubMed ID: 30442117
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ENO1, a potential prognostic head and neck cancer marker, promotes transformation partly via chemokine CCL20 induction.
    Tsai ST; Chien IH; Shen WH; Kuo YZ; Jin YT; Wong TY; Hsiao JR; Wang HP; Shih NY; Wu LW
    Eur J Cancer; 2010 Jun; 46(9):1712-23. PubMed ID: 20435467
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TGF-β-activated kinase-1: a potential prognostic marker for clear cell renal cell carcinoma.
    Wei C; Lai YQ; Li XX; Ye JX
    Asian Pac J Cancer Prev; 2013; 14(1):315-20. PubMed ID: 23534745
    [TBL] [Abstract][Full Text] [Related]  

  • 26. miR-210 is a prognostic marker in clear cell renal cell carcinoma.
    Samaan S; Khella HW; Girgis A; Scorilas A; Lianidou E; Gabril M; Krylov SN; Jewett M; Bjarnason GA; El-said H; Yousef GM
    J Mol Diagn; 2015 Mar; 17(2):136-44. PubMed ID: 25555365
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Decreased expression of NPRL2 in renal cancer cells is associated with unfavourable pathological, proliferation and apoptotic features.
    Tang Y; Jiang L; Tang W
    Pathol Oncol Res; 2014 Oct; 20(4):829-37. PubMed ID: 24789683
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic Value of a Long Non-coding RNA Signature in Localized Clear Cell Renal Cell Carcinoma.
    Qu L; Wang ZL; Chen Q; Li YM; He HW; Hsieh JJ; Xue S; Wu ZJ; Liu B; Tang H; Xu XF; Xu F; Wang J; Bao Y; Wang AB; Wang D; Yi XM; Zhou ZK; Shi CJ; Zhong K; Sheng ZC; Zhou YL; Jiang J; Chu XY; He J; Ge JP; Zhang ZY; Zhou WQ; Chen C; Yang JH; Sun YH; Wang LH
    Eur Urol; 2018 Dec; 74(6):756-763. PubMed ID: 30143382
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High expression of P53-induced Ring-h2 protein is associated with poor prognosis in clear cell renal cell carcinoma.
    Wu XR; Sha JJ; Liu DM; Chen YH; Yang GL; Zhang J; Chen YY; Bo JJ; Huang YR
    Eur J Surg Oncol; 2013 Jan; 39(1):100-6. PubMed ID: 23102595
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low expression of miR-126 is a prognostic marker for metastatic clear cell renal cell carcinoma.
    Khella HW; Scorilas A; Mozes R; Mirham L; Lianidou E; Krylov SN; Lee JY; Ordon M; Stewart R; Jewett MA; Yousef GM
    Am J Pathol; 2015 Mar; 185(3):693-703. PubMed ID: 25572155
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High NUCB2 expression level represents an independent negative prognostic factor in Chinese cohorts of non-metastatic clear cell renal cell carcinoma patients.
    Fu H; Zhu Y; Wang Y; Liu Z; Zhang J; Wang Z; Xie H; Dai B; Xu J; Ye D
    Oncotarget; 2017 May; 8(21):35244-35254. PubMed ID: 27806328
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The prognostic value of BAP1, PBRM1, pS6, PTEN, TGase2, PD-L1, CA9, PSMA, and Ki-67 tissue markers in localized renal cell carcinoma: A retrospective study of tissue microarrays using immunohistochemistry.
    Kim SH; Park WS; Park EY; Park B; Joo J; Joung JY; Seo HK; Lee KH; Chung J
    PLoS One; 2017; 12(6):e0179610. PubMed ID: 28654655
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of miR-21, miR-126 and miR-221 as prognostic factors of clear cell renal cell carcinoma with tumor thrombus of the inferior vena cava.
    Vergho DC; Kneitz S; Kalogirou C; Burger M; Krebs M; Rosenwald A; Spahn M; Löser A; Kocot A; Riedmiller H; Kneitz B
    PLoS One; 2014; 9(10):e109877. PubMed ID: 25279769
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vimentin over-expression and carbonic anhydrase IX under-expression are independent predictors of recurrence, specific and overall survival in non-metastatic clear-cell renal carcinoma: a validation study.
    Ingels A; Hew M; Algaba F; de Boer OJ; van Moorselaar RJ; Horenblas S; Zondervan P; de la Rosette JJ; Pilar Laguna Pes M
    World J Urol; 2017 Jan; 35(1):81-87. PubMed ID: 27207480
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNAs with prognostic potential for metastasis in clear cell renal cell carcinoma: a comparison of primary tumors and distant metastases.
    Heinzelmann J; Unrein A; Wickmann U; Baumgart S; Stapf M; Szendroi A; Grimm MO; Gajda MR; Wunderlich H; Junker K
    Ann Surg Oncol; 2014 Mar; 21(3):1046-54. PubMed ID: 24242678
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MiR-429 is linked to metastasis and poor prognosis in renal cell carcinoma by affecting epithelial-mesenchymal transition.
    Machackova T; Mlcochova H; Stanik M; Dolezel J; Fedorko M; Pacik D; Poprach A; Svoboda M; Slaby O
    Tumour Biol; 2016 Nov; 37(11):14653-14658. PubMed ID: 27619681
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic implications of Aquaporin 9 expression in clear cell renal cell carcinoma.
    Xu WH; Shi SN; Xu Y; Wang J; Wang HK; Cao DL; Shi GH; Qu YY; Zhang HL; Ye DW
    J Transl Med; 2019 Nov; 17(1):363. PubMed ID: 31703694
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nucleobindin 2 expression is an independent prognostic factor for clear cell renal cell carcinoma.
    Qi C; Ma H; Zhang HT; Gao JD; Xu Y
    Histopathology; 2015 Apr; 66(5):650-7. PubMed ID: 25322808
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic significance of two lipid metabolism enzymes, HADHA and ACAT2, in clear cell renal cell carcinoma.
    Zhao Z; Lu J; Han L; Wang X; Man Q; Liu S
    Tumour Biol; 2016 Jun; 37(6):8121-30. PubMed ID: 26715271
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The miR(21/10b) ratio as a prognostic marker in clear cell renal cell carcinoma.
    Fritz HKM; Lindgren D; Ljungberg B; Axelson H; Dahlbäck B
    Eur J Cancer; 2014 Jul; 50(10):1758-1765. PubMed ID: 24793999
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.